city_hall

Official websites use .boston.gov

A .boston.gov website belongs to an official government organization in the City of Boston.

lock

Secure .gov websites use HTTPS

A lock or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Last updated:

Zoning Commission remote hearing

The Zoning Commission will be holding a remote hearing on August 11 at 9 a.m. 

Attention: This meeting will only be held virtually and not in person. You can participate in this meeting by going to our online meeting. You may also submit written comments or questions to jeffrey.hampton@boston.gov

Discussion Topics

  1. Agenda

    9:00 AM         Map Amendment Application No. 735

                            Planned Development Area No. 129, Jan Karski Way, Dorchester

                            Map 5A/5B, Dorchester Neighborhood District     

                            Said map amendment would amend “Map 5A/5B, Dorchester Neighborhood District,” by adding the designation “D,” indicating a Planned Development Area overlay district to approximately 169,158 square feet (approximately 3.88 acres) of land generally bounded by Jan Karski Way on the west, Enterprise Street on the south, Boston Street on the east, and three-family and commercial parcels sharing the block to the north.   The proposed Development Plan includes an approximately 341,176 gross square foot transit-oriented residential development, creating approximately 403 new rental housing units, and includes 14,665 gross square feet of retail space, and significant improvements to the public realm.

    9:15 AM         First Amendment to the Development Plan for Planned Development Area No. 106

                            1000 Washington Street and 321 Harrison Avenue, South End

                            Said First Amendment amends the Development Plan to establish a review process for any proposed Research and Development Use on the site which would operate at BioSafety Level 3, as established by the U.S. Department of Health and Human Services (each, a "BSL-3 Sub-Use").

Back to top